| 公開日 | 2024.10.09 |
| 計算日 | 2024.06.13 |
| 企業名 | シンバイオ製薬 |
| 空売り企業・個人名 | UBS AG |
| investment_contractor | |
| investment_fund | |
| 残高割合 | 0.69% |
| 増減率 | -0.07 % |
| 残高数量 | 318200 |
| 増減量 | -34,575 |
| 前回計算日 | 06/11 |
| ステータス | |
| 備考 | We hereby provide corrected data as indicated on the left and cancel the report calculated on 2024-06-13 (The data below are for before the correction.) Ratio of Short Selling Positions to Shares Outstanding: 0.69% Number of Short Selling in Shares: 318,225 Number of Short Selling in Trading Units: 3,182 Date of Calculation in Previous Reporting: 2024/06/11 Ratio of Short Positions in Previous Reporting: 0.76% |
| Previous ShortPosition ID | 1030195 |
| 空売り機関 | 公開日 | 計算日 | 増減率 | 残高数量 | 増減量 | 残高割合 |
|---|---|---|---|---|---|---|
| JPM Securities Japan Co Ltd. | 2024-06-14 | 2024-06-13 | -0.09 % | 1,447,151 | -40,400 | 3.15% |
| MERRILL LYNCH INTERNATIONAL | 2024-06-17 | 2024-06-13 | +0.01 % | 1,218,499 | 3,400 | 2.65% |
| Nomura International plc | 2024-06-17 | 2024-06-13 | +0.28 % | 929,926 | 131,000 | 2.02% |
| GOLDMAN SACHS INTERNATIONAL | 2024-06-17 | 2024-06-13 | +0.06 % | 694,566 | 27,400 | 1.51% |
| モルガン･スタンレーMUFG証券株式会社 | 2024-06-13 | 2024-06-12 | +0.22 % | 650,727 | 100,900 | 1.41% |
| 計 | 4,940,869 | 計 | 10.74% | |||